| 210.80 Data as of Jun 18 |  +3.05 / +1.47%Today’s Change | 134.00 Today|||52-Week Range 242.64 | +44.02% Year-to-Date |
| DaVita and Myriad Join Forces - Analyst Blog Jun 18 / Zacks.com | J&J to Buy Aragon for $1 Billion - Analyst Blog Jun 18 / Zacks.com |
| Is Elan Pushing Its Luck? Jun 18 / MotleyFool.com | Good News for Celgene's Pipeline - Analyst Blog Jun 18 / Zacks.com |
| Elan Likely To Receive Higher Takeout Bids Jun 18 / MotleyFool.com | Elan Explores Sale Options - Analyst Blog Jun 17 / Zacks.com |
| Perrigo in Expansion Mode - Analyst Blog Jun 18 / Zacks.com | Amgen Xgeva Label Expanded - Analyst Blog Jun 17 / Zacks.com |
| Teva to Acquire MicroDose Therapeutx - Analyst Blog Jun 18 / Zacks.com | Myriad: End to Legal Battle over Patents - Analyst Blog Jun 17 / Zacks.com |
| Previous close | 207.75 |
| Today’s open | 210.47 |
| Day’s range | -- - -- |
| Volume | 1,440,775 |
| Average volume (3 months) | 1,489,011 |
| Market cap | $49.3B |
| Dividend yield | -- |
| Earnings growth (last year) | +14.29% |
| Earnings growth (this year) | +24.17% |
| Earnings growth (next 5 years) | +18.50% |
| Revenue growth (last year) | +7.78% |
| P/E ratio | 33.5 |
| Price/Sales | 6.35 |
| Price/Book | 7.06 |
| Today’s change | Today’s % change | |
|---|---|---|
| BAXBaxter International... | +0.15 | +0.21% |
| AMGNAmgen Inc | +2.42 | +2.44% |
| GILDGilead Sciences Inc | +0.91 | +1.78% |
| LIFELife Technologies Co... | +0.03 | +0.04% |
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $1.90 |
| Annual revenue (last year) | $5.5B |
| Annual profit (last year) | $1.4B |
| Net profit margin | 25.18% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director George A. Scangos, PhD |
Chief Financial Officer & Executive Vice President Paul J. Clancy, MBA |
Corporate headquarters Weston, Massachusetts |
.
